| |
|
|
|
Enlivex Therapeutics Ltd  
|
|
8.62 0.26 (0.03%) |
11-27 13:00 |
|
Open: |
8.51 |
Pre close: |
8.36 |
Target:
|
13.21
|
|
High: |
8.95 |
Low: |
8.4 |
Resistance:
|
11.31
13.40
|
|
Volume: |
81,616 |
Market Cap: |
116M |
Support:
|
7.92
6.59
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.42
 |
MACD |
MACD(12,26):
|
-0.67 |
|
MA(20): |
9.67  |
Signal(12,26,9): |
-0.50 |
|
MA(100): |
7.65 |
Stochastic Oscillator |
%K(14,3):
|
12.92 |
|
MA(250): |
7.04 |
%D(3): |
10.65 |
|
Average Volume(K) |
3-Month: |
118258
|
52-Week |
High:
|
16.94 |
|
10-Days: |
12848 |
Low: |
3.59 |
|
RSI |
RSI(14):
|
41.38 |
Change(%): |
0.3 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
0.0 |
Shares Float (M) |
0.00 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-1.400 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.000 |
EBITDA (p.s.) |
-0.658 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.00 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
